Research Project
Project Title: |
Multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of Obinutuzumab in patients with class III or IV lupus nephritis according to ISN / RPS 2003 criteria |
Project Type: |
Clinical Trial, Enrolment ongoing |
Disease group(s): |
Immune glomerulopathies |
Project Summary: |
Multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of Obinutuzumab in patients with class III or IV lupus nephritis according to ISN / RPS 2003 criteria. |
Lead principal investigator(s): |
Dario Roccatello, Turin |
Project Period: |
09/2020 - 01/2050 |
Sponsors: |
Industry |
ClinicalTrials.gov: |
NCT04221477 |
EudraCT Nr.: |
2019-004034-42 |
« Back to research page